
The cultural phenomenon of GLP-1 drugs solidifies Novo Nordisk (NVO) as a high-conviction investment due to its massive and growing revenue stream. The rapid, disruptive progress in generative AI reinforces it as a core long-term theme, with exposure through leaders like NVIDIA (NVDA) and Microsoft (MSFT). In Las Vegas, positive feedback on renovated properties suggests MGM Resorts (MGM) is a strong investment, as its capital spending is enhancing asset value and appeal. This strategy positions MGM favorably against competitors with aging properties. The "humanization of pets" trend also offers a durable growth opportunity through companies like IDEXX Laboratories (IDXX) and Zoetis (ZTS).